Mode
Text Size
Log in / Sign up
N/A N=46 Randomized Single-blind Treatment

Morning Light Treatment for Traumatic Stress: The Role of Amygdala Reactivity

Stress

Enrolled (actual)
46
Serious AEs
0.0%
Results posted
Mar 2024
Primary outcome: Primary: Change in Amygdala Reactivity as Measured by Blood-oxygen-level-dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Signal — 0.1287; 0.1532; 0.2134; 0.1048 beta weights

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Light therapy A via the Re-Timer® (Device); Light therapy B via the Re-Timer® (Device); Light therapy C via the Re-Timer® (Device)
Age
Adult · 18+ yrs
Sex
All
Sponsor
University of Michigan
Primary completion
Mar 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Amygdala Reactivity as Measured by Blood-oxygen-level-dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Signal
0.1287; 0.1532; 0.2134; 0.1048; 0.1248; 0.0806

Summary

The purpose of this study is to determine the effect of different amounts of time of morning light on brain emotional processing.

Eligibility Criteria

Inclusion Criteria

  • Meets criteria for traumatic stress
  • Normal or corrected to normal vision
  • Right-handed
  • Fluency in English
  • Physically able to travel for study visit attendance

Exclusion Criteria

  • Significant chronic uncontrolled disease (e.g. uncontrolled diabetes, advanced liver disease, cancer, etc.)
  • Severe hearing problem
  • Intellectual disability or serious cognitive impairment
  • Inability to tolerate enclosed spaces (e.g. the MRI machine)
  • Ferrous-containing metals within the body
  • Pregnant, trying to get pregnant, or breastfeeding
  • Epilepsy
  • Other research participation
  • Frequent number of special events during study period (weddings, concerts, exams, etc.)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04117347). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search